This specialty practice discussion group is intended for advanced practice professionals of APHON.... View more
This specialty practice discussion group is intended for advanced practice professionals of APHON. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
Are you sure you want to leave ?
Reply To: Bortezomib During DI for T Cell Lymphoma
Thank you, our plan is to start induction with the 1231 with Bortezomib and switch to the 0434 as well. We ended up needing to get Bortezomib from the drug company due to insurance denial.
—————————— Katherine Trimble, CPHON,CPNP,MSN,RN Pediatric Oncology Nurse Educator Winfield, IL United States —————————— ——————————————- Original Message: Sent: 05-06-2022 12:37 PM From: Shari Feinberg Subject: Bortezomib During DI for T Cell Lymphoma
We also use 1231 induction without Bortezomib and switch to AALL 0434 from consolidation forward. We will adjust our approach when data is final.
Original Message: Sent: 05-06-2022 09:04 AM From: Maureen Lynch Baker Subject: Bortezomib During DI for T Cell Lymphoma
We use the 1231 induction without Bortezomib and then switch to AALL0434 starting with consolidation. The data on the 1231 comparing the regular induction with Bortezomib is not final, so we are using the standard induction for that protocol.
Maureen Baker APN, MSN, PCNS-BC, CPNP, CPON
Pediatric Hematology/Oncology Advanced Practice Nurse
Original Message: Sent: 05-05-2022 02:13 PM From: Katherine Trimble Subject: Bortezomib During DI for T Cell Lymphoma
HI Breanne, We have a newly diagnosed patient with T-cell lymphoma. WE are planning to give the bortezomib 1.4.8 and 11. We are having difficulty getting insurance approval. BCBS. We did a peer to peer. Send references. Did you have difficulty? Do you have any suggestions? Thank you, Kathy Trimble MSN, RN, CPNP Pediatric Hematology/Oncology Nurse Practitioner Northwestern Medicine Central DuPage Hospital Winfield, IL
—————————— Katherine Trimble, CPHON,CPNP,MSN,RN Pediatric Oncology Nurse Educator Winfield, IL United States
Original Message: Sent: 05-05-2022 12:48 PM From: Breanne Roche Subject: Bortezomib During DI for T Cell Lymphoma
I was wondering what institutions are using bortezomib during DI for T Cell lymphoma patients. If you are using it, are you giving it on Days 1, 4, 8, & 11?